JPMorgan Predicts S&P 500 Could Reach 6,144 Points Amid Bullish Momentum

Paul Lee 특파원 / 기사승인 : 2025-05-21 03:25:43
  • -
  • +
  • 인쇄

Photo = Yonhap news

 

 

[Alpha Biz= Paul Lee] As the New York stock market continues its upward trajectory, global investment bank JPMorgan has issued a short-term bullish outlook, suggesting that the S&P 500 index could climb to 6,144 points.

According to industry sources on May 20, JPMorgan stated in a recent report that markets are currently in a phase where "good news is rewarded, and bad news is ignored." While a short-term correction remains possible, the firm believes the broader uptrend is unlikely to reverse.



Key catalysts highlighted by JPMorgan include:

Nvidia's earnings report scheduled for May 28

Progress in trade negotiations between the U.S., China, the EU, and Canada

Seasonal strength in June and July

Resilient employment and consumer data

A strong M&A market


Potential short-term risks include weak Nvidia earnings, stalled trade talks, and profit-taking pressures.



JPMorgan emphasized the potential rebound of mega-cap tech stocks — the so-called "Magnificent 7 (M7)" — and cyclical stocks. As of May 15, the S&P 500 had gained 0.6% year-to-date, while the M7 group had posted a -4.7% return, suggesting room for further upside.




Specific positive catalysts cited include:

For Nvidia: momentum from AI computing expansion and geopolitical tailwinds from U.S. engagement in the Middle East

For Tesla: the launch of its robotaxi service in June, introduction of affordable EVs, and a perceived reduction in CEO Elon Musk’s political distractions

 

 

 

 

알파경제 Paul Lee 특파원(hoondork1977@alphabiz.co.kr)

어플

주요기사

Amazon Shares Soar 9% After AI-Driven AWS Growth Pushes Earnings Far Beyond Expectations2025.10.31
China Officially Confirms Xi–Trump Summit to Be Held in Busan on October 302025.10.30
NVIDIA CEO Jensen Huang Hints at “Exciting Announcement” for South Korea During GTC 20252025.10.29
Novartis to Acquire Avidity Biosciences for USD 12 Billion, Strengthening RNA Therapeutics Portfolio2025.10.28
Target to Cut 1,800 Corporate Jobs Amid Prolonged Sales Slump2025.10.24
뉴스댓글 >

건강이 보이는 대표 K Medical 뉴스

HEADLINE

PHOTO

많이 본 기사